AEON Biopharma, Inc.

📍 Irvine, United States👥 8 employees💰 Last funded Nov 2018
Pharmaceutical Manufacturing🌐 aeonbiopharma.com
Website LinkedIn
AEON Biopharma is a biopharmaceutical company focused on developing ABP-450 (prabotulinumtoxinA) injection for the treatment of debilitating medical conditions. The company is dedicated to innovation in the rapidly expanding therapeutic botulinum toxin market. This therapeutic-only focus will allow AEON Biopharma to advance safe and effective treatment options to patients, while delivering differentiated economics to payors and physicians. The company continues to evaluate additional therapeutic indications for development based on a comprehensive product assessment process designed to identify those indications where it believes ABP-450 can attain clinical, regulatory and commercial success.
1
Total investors
0
Early stage
0
Mid stage
0
Late stage
—
Founded

Investors

1 investor
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
1
Frequently asked questions
Who invested in AEON Biopharma, Inc.?
AEON Biopharma, Inc. has 1 investor on record on gritt.io.
When did AEON Biopharma, Inc. last raise funding?
The most recent investment in AEON Biopharma, Inc. recorded on gritt.io was in November 2018.
What industry is AEON Biopharma, Inc. in?
AEON Biopharma, Inc. operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is AEON Biopharma, Inc. based?
AEON Biopharma, Inc. is headquartered in Irvine, United States.